Home / Health / Dementia Care: From Despair to Hope on the NHS
Dementia Care: From Despair to Hope on the NHS
7 Mar
Summary
- Dementia is the UK's leading cause of death and most feared condition.
- New drugs offer hope by delaying Alzheimer's progress for months.
- A modest £6 million could pilot trials for newly licensed Alzheimer's drugs.

Dementia, the leading cause of death in the UK and a condition widely feared, is frequently miscategorized as an inevitable part of aging or a social care issue. This viewpoint neglects its status as serious neurological diseases requiring the same clinical focus as cancer or heart disease. The scale of the challenge is immense, with projections of 1.4 million people living with dementia by 2040, yet the current system exhibits defeatism and despair.
This pessimism has tangible consequences for families, who often receive minimal support after diagnosis, leaving them to manage complex needs alone. However, a more hopeful approach is possible. Newly licensed drugs can delay the progression of Alzheimer's disease for months in early stages. Hundreds more promising treatments are in development.




